These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30968639)

  • 1. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
    İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
    Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
    Karimi M
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
    Wong WY; Huang WC; Miller R; McGinty K; Whisnant JK
    Haemophilia; 2000 Jan; 6(1):50-4. PubMed ID: 10632743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
    Sun Y; Jia L; Yang Z; Chen W
    Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
    Farah RA; Hamod D; Melick N; Giansily-Blaizot M; Sallah S
    J Thromb Haemost; 2007 Feb; 5(2):433-4. PubMed ID: 17109737
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
    Désage S; Chamouard V; Meunier S; Enjolras N; Sobas F; Négrier C; Le Quellec S
    Haemophilia; 2021 Jul; 27(4):e487-e490. PubMed ID: 33215792
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitor development after liver transplantation in congenital factor VII deficiency.
    See WS; Chang KO; Cheuk DK; Leung YY; Chan GC; Chan SC; Ha SY
    Haemophilia; 2016 Sep; 22(5):e417-22. PubMed ID: 27501477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
    Jenabali Jahromi B; Karimi M
    Haemophilia; 2011 Jul; 17(4):713-5. PubMed ID: 21299748
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
    Shams M; Dorgalaleh A; Safarian N; Emami AH; Zaker F; Tabibian S; Managhchi MR; Faranoush M; Tabatabaei T; Satari S; Rezvani MR
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):24-28. PubMed ID: 30585836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
    Liu N; Aldea S; François D; Cherqui-Michel M; Giansily-Blaizot M; Fischler M
    Br J Anaesth; 2009 Dec; 103(6):858-60. PubMed ID: 19846405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
    Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
    Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare combination: congenital factor VII deficiency with Chiari malformation.
    Bay A; Aktekin E; Erkutlu I
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):946-8. PubMed ID: 26248161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency.
    Chuansumrit A; Visanuyothin N; Puapunwattana S; Chaivisuth A; Rasmidat P; Charoenkwan P; Chiemchanya S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1059-64. PubMed ID: 12549776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
    Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent intracranial haemorrhages in a patient with factor seven deficiency: a case report.
    Fadzil F
    Med J Malaysia; 2011 Aug; 66(3):261-3. PubMed ID: 22111455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
    Lapecorella M; Mariani G;
    Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
    Cramer TJ; Anderson K; Navaz K; Brown JM; Mosnier LO; von Drygalski A
    Blood Cells Mol Dis; 2016 Mar; 57():8-12. PubMed ID: 26852649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.